EXCLUSIVE: Industry veteran Peter Johnson has joined Skydance as a television executive reporting to Skydance Television President Bill Bost. Johnson previously did a two-year stint as President of…
for Hulu.
Prior to that he spent nine years at McG’s Wonderland Sound & Vision, serving as President of Television & Digital Media and Executive Producer of content, shepherding such shows as Johnson began his career at Fox Broadcasting where he started in research before switching to development and rising to SVP of Drama Development for the network, developing such series as
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Johnson & Johnson Shares Jump In Premarket As Firm Plans To Split Into Two Separate CompaniesI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Read more »
Johnson & Johnson to split into two companies, separating consumer health businessShares of Johnson & Johnson jumped in premarket trading Friday, after the health care giant announced it its splitting itself into two publicly traded
Read more »
WSJ News Exclusive | Johnson & Johnson Plans to Split Into Two Public CompaniesJohnson & Johnson intends to separate its high-margin but risky prescription-drugs and medical-devices business from its storied but slower-growing consumer group, creating two publicly traded companies.
Read more »
EU lists rare spinal condition as side-effect of J&J COVID-19 shotEurope's drug regulator on Thursday recommended adding a rare type of spinal inflammation called transverse myelitis as a side-effect of Johnson & Johnson's single-dose COVID-19 vaccine.
Read more »
Johnson & Johnson to split into two companiesJohnson & Johnson is splitting into two companies, separating the division that sells Band-Aids and Listerine, from its medical device and prescription drug business. The company said Friday the move will help improve the focus and speed of each company to address trends in their different industries.
Read more »
Johnson & Johnson to split into two companiesJohnson & Johnson says it will separate its segment that sells Band-Aids, Listerine and over-the-counter medicines from its pharmaceutical and medical device business
Read more »